336 related articles for article (PubMed ID: 34404403)
1. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology.
Valletti M; Eshmuminov D; Gnecco N; Gutschow CA; Schneider PM; Lehmann K
World J Surg Oncol; 2021 Aug; 19(1):245. PubMed ID: 34404403
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of peritoneal lavage cytology and chemotherapy during surgery for advanced gastric cancer.
Funami Y; Tokumoto N; Miyauchi H; Ochiai T; Kuga K
Int Surg; 1999; 84(3):220-4. PubMed ID: 10533780
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Neoadjuvant Chemotherapy to Surgery Followed by Adjuvant Chemotherapy in Japanese Patients with Peritoneal Lavage Cytology Positive for Gastric Carcinoma.
Yamamoto M; Kawano H; Yamaguchi S; Egashira A; Minami K; Taguchi K; Ikeda Y; Morita M; Toh Y; Okamura T
Anticancer Res; 2015 Sep; 35(9):4859-63. PubMed ID: 26254379
[TBL] [Abstract][Full Text] [Related]
4. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
5. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
[TBL] [Abstract][Full Text] [Related]
7. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.
Al-Batran SE; Homann N; Pauligk C; Goetze TO; Meiler J; Kasper S; Kopp HG; Mayer F; Haag GM; Luley K; Lindig U; Schmiegel W; Pohl M; Stoehlmacher J; Folprecht G; Probst S; Prasnikar N; Fischbach W; Mahlberg R; Trojan J; Koenigsmann M; Martens UM; Thuss-Patience P; Egger M; Block A; Heinemann V; Illerhaus G; Moehler M; Schenk M; Kullmann F; Behringer DM; Heike M; Pink D; Teschendorf C; Löhr C; Bernhard H; Schuch G; Rethwisch V; von Weikersthal LF; Hartmann JT; Kneba M; Daum S; Schulmann K; Weniger J; Belle S; Gaiser T; Oduncu FS; Güntner M; Hozaeel W; Reichart A; Jäger E; Kraus T; Mönig S; Bechstein WO; Schuler M; Schmalenberg H; Hofheinz RD;
Lancet; 2019 May; 393(10184):1948-1957. PubMed ID: 30982686
[TBL] [Abstract][Full Text] [Related]
8. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Al-Batran SE; Hofheinz RD; Pauligk C; Kopp HG; Haag GM; Luley KB; Meiler J; Homann N; Lorenzen S; Schmalenberg H; Probst S; Koenigsmann M; Egger M; Prasnikar N; Caca K; Trojan J; Martens UM; Block A; Fischbach W; Mahlberg R; Clemens M; Illerhaus G; Zirlik K; Behringer DM; Schmiegel W; Pohl M; Heike M; Ronellenfitsch U; Schuler M; Bechstein WO; Königsrainer A; Gaiser T; Schirmacher P; Hozaeel W; Reichart A; Goetze TO; Sievert M; Jäger E; Mönig S; Tannapfel A
Lancet Oncol; 2016 Dec; 17(12):1697-1708. PubMed ID: 27776843
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
10. Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.
Nakayama I; Chin K; Matsushima T; Takahari D; Ogura M; Shinozaki E; Suenaga M; Ozaka M; Wakatsuki T; Ichimura T; Hiroki O; Yamaguchi K
Int J Clin Oncol; 2017 Dec; 22(6):1060-1068. PubMed ID: 28748355
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative peritoneal lavage cytology offers prognostic significance for gastric cancer patients with curative resection.
Higaki E; Yanagi S; Gotohda N; Kinoshita T; Kuwata T; Nagino M; Ochiai A; Fujii S
Cancer Sci; 2017 May; 108(5):978-986. PubMed ID: 28256061
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
[TBL] [Abstract][Full Text] [Related]
15. Staging laparoscopy with peritoneal lavage to identify peritoneal metastases and free intraperitoneal cancer cells in the management of locally advanced gastric cancer.
Huang B; Rampulla V; Ri M; Lindblad M; Nilsson M; Rouvelas I; Klevebro F
Eur J Surg Oncol; 2024 Jun; 50(6):108059. PubMed ID: 38503223
[TBL] [Abstract][Full Text] [Related]
16. Long-term adjuvant chemotherapy after resection for pancreatic cancer patients with positive peritoneal lavage cytology.
Ohgi K; Sugiura T; Okamura Y; Ashida R; Yamada M; Otsuka S; Todaka A; Uesaka K
Langenbecks Arch Surg; 2023 Apr; 408(1):165. PubMed ID: 37103587
[TBL] [Abstract][Full Text] [Related]
17. [The treatment strategy for type 4 gastric cancer with positive lavage cytology--a decision making of the therapeutic strategy by the change of the result of the lavage cytology].
Nunobe S; Iwasaki Y; Ohashi M; Shirou I; Takahashi K; Yamaguchi T; Matsumoto H; Yasutome M
Gan To Kagaku Ryoho; 2007 Nov; 34(12):1952-4. PubMed ID: 18219862
[TBL] [Abstract][Full Text] [Related]
18. The Importance of Extensive Intraoperative Peritoneal Lavage as a Promising Method in Patients with Gastric Cancer Showing Positive Peritoneal Cytology Without Overt Peritoneal Metastasis and Other Therapeutic Approaches.
Ilhan E; Alemdar A; Ureyen O; Bas K
J Invest Surg; 2017 Oct; 30(5):318-324. PubMed ID: 27806214
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.
Jamel S; Markar SR; Malietzis G; Acharya A; Athanasiou T; Hanna GB
Gastric Cancer; 2018 Jan; 21(1):10-18. PubMed ID: 28779261
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
